"analysisId","analysisDescription","outcomeId","outcomeName","comparatorId","comparatorName","targetId","targetName","rr","ci95lb","ci95ub","p","target","comparator","targetDays","comparatorDays","eventsTarget","eventsComparator","logRr","seLogRr","llr"
1,"OT - PS matching",30234,"Neck sprain",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",4114197,"Tumor of hypothalamus",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",134765,"Cachexia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",377535,"Sleep walking disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",194997,"Prostatitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",1792374,"[GDE2025_Antiplatelet] Secondary outcome - GI bleeding",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4013,6697,1,0,NA,NA,NA
1,"OT - PS matching",436100,"Narcolepsy",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",377910,"Deviated nasal septum",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",1792369,"[GDE2025_Antiplatelet] Secondary outcome - Ischemic event",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",0.135335283236613,NA,1.9661485474312,NA,16,16,4014,4251,0,3,-2,NA,1.13243833903395
1,"OT - PS matching",261880,"Atelectasis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",135215,"Hashimoto thyroiditis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",30441,"Sialolithiasis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",199074,"Acute pancreatitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",4135082,"Dislocation of distal radioulnar joint",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",1792365,"[GDE2025_Antiplatelet] Secondary outcome - Cardiovascular mortality",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,1,0,NA,NA,NA
1,"OT - PS matching",138463,"Aphthous ulcer of mouth",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",72418,"Scoliosis deformity of spine",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",1792370,"[GDE2025_Antiplatelet] Secondary outcome - AMI",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",0.135335283236613,NA,1.9661485474312,NA,16,16,4014,6571,0,2,-2,NA,1.13243833903395
1,"OT - PS matching",4142905,"Fracture of rib",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",199861,"Perianal abscess",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",75576,"Irritable bowel syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",436676,"Posttraumatic stress disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",381581,"Chalazion",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",440424,"Aphasia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",380094,"Carpal tunnel syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",72576,"Benign tumor of breast",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",201792,"Nongonococcal urethritis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",376707,"Acute conjunctivitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",4150372,"Acute otitis media",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",4047787,"Colles' fracture",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",1792372,"[GDE2025_Antiplatelet] Secondary outcome - Stroke(hemorrhagic)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",1792367,"[GDE2025_Antiplatelet] Primary outcome - MACE",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",9.59713049391343e-10,NA,1.6128994352159,NA,16,16,4014,4251,1,3,-20.7643867830323,NA,1.38629435728104
1,"OT - PS matching",140168,"Psoriasis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",198202,"Cystocele",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",4153877,"Post-traumatic wound infection",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",73300,"Radial styloid tenosynovitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",4215978,"Onychomycosis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",42873169,"Sprain of shoulder rotator cuff",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",374366,"Sensorineural hearing loss",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",261326,"Viral pneumonia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",140362,"Hypoparathyroidism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",444367,"Cholelithiasis without obstruction",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",74189,"Sprain of cruciate ligament of knee",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",380731,"Otitis externa",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",4299544,"Acanthosis nigricans",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",4172458,"Candidiasis of skin",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",4028970,"Tracheobronchitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",380839,"Tuberous sclerosis syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",133228,"Dental caries",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",4218106,"Alcoholism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",74855,"Genital herpes simplex",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",439840,"Lymphangitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",4001458,"Fatigue fracture of vertebra",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",4171915,"Orchitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",4304008,"Memory impairment",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",381444,"Contusion of eye",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",433527,"Endometriosis (clinical)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",141933,"Alopecia areata",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",438407,"Bulimia nervosa",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",134619,"Toxic nodular goiter",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",436675,"Anorexia nervosa",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",432590,"Delusional disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",434626,"Borderline personality disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",437082,"Ankylosing spondylitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",4239381,"Psychoactive substance abuse",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",318800,"Gastroesophageal reflux disease",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",2.33333333333333,0.648695890738148,10.8261315327973,0.238009145163974,16,16,2661,5311,7,5,0.847297860387204,0.718062697480801,0.822828785050518
1,"OT - PS matching",77965,"Acquired trigger finger",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",1792371,"[GDE2025_Antiplatelet] Secondary Outcome - Stroke(both)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,4377,0,1,NA,NA,NA
1,"OT - PS matching",192606,"Paraplegia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",4108467,"Burn of skin",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",435093,"Closed fracture of femur",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",197036,"Vesicoureteric reflux",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",440129,"Hypertrophy of nasal turbinates",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",253796,"Pneumothorax",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",195212,"Hypercortisolism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",80509,"Bone cyst",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",4280571,"Acute pyelonephritis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",194696,"Dysmenorrhea",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",4288544,"Inguinal hernia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",198803,"Benign prostatic hyperplasia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",1,0.0395799610481354,25.2653103620755,1,16,16,4003,6333,1,1,0,1.64769982939051,0
1,"OT - PS matching",81336,"Rectal prolapse",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",433440,"Dysthymia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",1792366,"[GDE2025_Antiplatelet] Secondary outcome - NACE",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",9.59713049391343e-10,NA,1.6128994352159,NA,16,16,4013,4251,1,3,-20.7643867830323,NA,1.38629435728104
1,"OT - PS matching",4068482,"Prolapsed lumbar intervertebral disc",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",4207307,"Infective meningitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",378424,"Astigmatism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",4092565,"Uterine prolapse",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",4339088,"Testicular mass",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",316457,"Mallory-Weiss syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",380395,"Retinal dystrophy",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",374655,"Mastoiditis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",81878,"Benign paroxysmal positional vertigo",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",1792364,"[GDE2025_Antiplatelet] Secondary outcome - All cause mortality",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,1,0,NA,NA,NA
1,"OT - PS matching",139902,"Allergic urticaria",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",40443308,"Polycystic ovary syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",376132,"Ectropion",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",4079750,"Osteoarthritis of knee",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",4164337,"Polyp of large intestine",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",4049417,"Vesicular eczema",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",440814,"Torticollis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",435613,"Cellulitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",376938,"Neurofibromatosis syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",4131595,"Fracture of radius",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",1792373,"[GDE2025_Antiplatelet] Secondary outcome - Stroke(ischemic)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,4377,0,1,NA,NA,NA
1,"OT - PS matching",198075,"Condyloma acuminatum of the anogenital region",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",134453,"Bursitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",373478,"Presbyopia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",4223947,"Viral hepatitis, type A",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",1792368,"[GDE2025_Antiplatelet] Secondary outcome - Hemorrhagic event",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4013,6697,1,0,NA,NA,NA
1,"OT - PS matching",433450,"Paranoid schizophrenia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
1,"OT - PS matching",141323,"Acute maxillary sinusitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,16,16,4014,6697,0,0,NA,NA,NA
2,"OT - PS stratification",74189,"Sprain of cruciate ligament of knee",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",373478,"Presbyopia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",71734589079535.8,0.0286051608181276,NA,NA,819,16,229419,6697,4,0,31.9039941611505,NA,0.07111343067535
2,"OT - PS stratification",134765,"Cachexia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",201792,"Nongonococcal urethritis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",72576,"Benign tumor of breast",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",139902,"Allergic urticaria",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",105049314929394,0.0118571328024245,NA,NA,819,16,229825,6697,2,0,32.2854510218217,NA,0.0378462540983548
2,"OT - PS stratification",1792368,"[GDE2025_Antiplatelet] Secondary outcome - Hemorrhagic event",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",67105282504275.3,0.181938445899858,NA,NA,819,16,227838,6697,18,0,31.8372838826536,NA,0.392931837805207
2,"OT - PS stratification",381444,"Contusion of eye",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",1792371,"[GDE2025_Antiplatelet] Secondary Outcome - Stroke(both)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",0.112610634955183,0.0179445522767227,2.16797497627248,0.0741715170412145,819,16,229986,4377,5,1,-2.18381911875626,1.2230485568771,1.21929265433648
2,"OT - PS stratification",436100,"Narcolepsy",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,229844,6697,1,0,NA,NA,NA
2,"OT - PS stratification",140362,"Hypoparathyroidism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",138463,"Aphthous ulcer of mouth",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",433440,"Dysthymia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,229479,6697,2,0,NA,NA,NA
2,"OT - PS stratification",194997,"Prostatitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,229796,6697,1,0,NA,NA,NA
2,"OT - PS stratification",4164337,"Polyp of large intestine",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",75222482245574.7,0.0576732209809281,NA,NA,819,16,228608,6697,7,0,31.9514712682345,NA,0.126543097895919
2,"OT - PS stratification",1792369,"[GDE2025_Antiplatelet] Secondary outcome - Ischemic event",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",0.195426324557331,0.0695266092278065,0.815900961445618,0.00935721574152831,819,16,223795,4251,30,3,-1.63257182706921,0.62822160263199,2.38836700569493
2,"OT - PS stratification",4108467,"Burn of skin",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",1792367,"[GDE2025_Antiplatelet] Primary outcome - MACE",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",0.283012175499824,0.103297346965968,1.16750259378304,0.0413105911740676,819,16,223466,4251,44,3,-1.26226535929678,0.61863649978682,1.58383435025144
2,"OT - PS stratification",380395,"Retinal dystrophy",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",133228,"Dental caries",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",123334940312865,0.0894821516095671,NA,NA,819,16,227560,6697,8,0,32.4459248623776,NA,0.172610760455406
2,"OT - PS stratification",376132,"Ectropion",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",4001458,"Fatigue fracture of vertebra",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",93083860089411.8,0.020067937791183,NA,NA,819,16,229313,6697,3,0,32.1645219241668,NA,0.0520392535330565
2,"OT - PS stratification",440814,"Torticollis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",4131595,"Fracture of radius",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,229347,6697,2,0,NA,NA,NA
2,"OT - PS stratification",1792372,"[GDE2025_Antiplatelet] Secondary outcome - Stroke(hemorrhagic)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",68780680769049.1,0.0208882595150011,NA,NA,819,16,230020,6697,3,0,31.8619440186599,NA,0.0550985316580217
2,"OT - PS stratification",197036,"Vesicoureteric reflux",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",439840,"Lymphangitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",318800,"Gastroesophageal reflux disease",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",1.18894805345788,0.537271876030814,3.39104610563334,0.712703908057277,819,16,165823,5311,249,5,0.173068927484168,0.470005954143057,0.0744109045344885
2,"OT - PS stratification",77965,"Acquired trigger finger",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,229981,6697,1,0,NA,NA,NA
2,"OT - PS stratification",4079750,"Osteoarthritis of knee",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,228998,6697,4,0,NA,NA,NA
2,"OT - PS stratification",134453,"Bursitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230111,6697,1,0,NA,NA,NA
2,"OT - PS stratification",1792365,"[GDE2025_Antiplatelet] Secondary outcome - Cardiovascular mortality",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",53392030410407.3,0.11453888239999,NA,NA,819,16,230025,6697,11,0,31.608682607506,NA,0.216850340349026
2,"OT - PS stratification",4171915,"Orchitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",81336,"Rectal prolapse",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",30234,"Neck sprain",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,229824,6697,2,0,NA,NA,NA
2,"OT - PS stratification",4299544,"Acanthosis nigricans",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",433527,"Endometriosis (clinical)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230008,6697,1,0,NA,NA,NA
2,"OT - PS stratification",433450,"Paranoid schizophrenia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",376938,"Neurofibromatosis syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",378424,"Astigmatism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",66797336489520.1,0.122039981024457,NA,NA,819,16,227281,6697,12,0,31.8326843227648,NA,0.229664647726921
2,"OT - PS stratification",141933,"Alopecia areata",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",4218106,"Alcoholism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230021,6697,2,0,NA,NA,NA
2,"OT - PS stratification",30441,"Sialolithiasis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",380731,"Otitis externa",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",192606,"Paraplegia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",261326,"Viral pneumonia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",4223947,"Viral hepatitis, type A",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",135215,"Hashimoto thyroiditis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230108,6697,2,0,NA,NA,NA
2,"OT - PS stratification",74855,"Genital herpes simplex",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",435613,"Cellulitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,229705,6697,2,0,NA,NA,NA
2,"OT - PS stratification",437082,"Ankylosing spondylitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,229705,6697,2,0,NA,NA,NA
2,"OT - PS stratification",199861,"Perianal abscess",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",194696,"Dysmenorrhea",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",4288544,"Inguinal hernia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",174673623340252,0.0300814146419926,NA,NA,819,16,229062,6697,4,0,32.7939403390722,NA,0.0777848748940215
2,"OT - PS stratification",376707,"Acute conjunctivitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",181898088338226,0.0116596051129819,NA,NA,819,16,230102,6697,2,0,32.8344676919869,NA,0.0374193953243491
2,"OT - PS stratification",380094,"Carpal tunnel syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",381581,"Chalazion",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",1792373,"[GDE2025_Antiplatelet] Secondary outcome - Stroke(ischemic)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",0.0531621236283094,0.00503577016188589,1.1520998016661,0.0342366149871179,819,16,230093,4377,2,1,-2.93440909807364,1.38593745538907,1.78973883182522
2,"OT - PS stratification",141323,"Acute maxillary sinusitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",438407,"Bulimia nervosa",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",198803,"Benign prostatic hyperplasia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",1.15826560370865,0.255131515930478,20.4718430380131,0.895506169907542,819,16,214680,6333,57,1,0.14692371702068,1.11864977731518,0.0111208221425159
2,"OT - PS stratification",432590,"Delusional disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",436675,"Anorexia nervosa",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",316457,"Mallory-Weiss syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",436676,"Posttraumatic stress disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,229889,6697,1,0,NA,NA,NA
2,"OT - PS stratification",440129,"Hypertrophy of nasal turbinates",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,229791,6697,1,0,NA,NA,NA
2,"OT - PS stratification",380839,"Tuberous sclerosis syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",377910,"Deviated nasal septum",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,228279,6697,3,0,NA,NA,NA
2,"OT - PS stratification",374655,"Mastoiditis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",1792374,"[GDE2025_Antiplatelet] Secondary outcome - GI bleeding",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",328661905534439,0.231832201803988,NA,NA,819,16,227945,6697,15,0,33.4260506955546,NA,0.337434521085726
2,"OT - PS stratification",4304008,"Memory impairment",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",40443308,"Polycystic ovary syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",1792364,"[GDE2025_Antiplatelet] Secondary outcome - All cause mortality",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",61712738928031.3,0.129893927531359,NA,NA,819,16,229807,6697,14,0,31.7535114911371,NA,0.27175019596298
2,"OT - PS stratification",81878,"Benign paroxysmal positional vertigo",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,229710,6697,2,0,NA,NA,NA
2,"OT - PS stratification",374366,"Sensorineural hearing loss",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,227573,6697,3,0,NA,NA,NA
2,"OT - PS stratification",4280571,"Acute pyelonephritis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",107328408353946,0.0431594404825237,NA,NA,819,16,229092,6697,5,0,32.306914486851,NA,0.110285038721205
2,"OT - PS stratification",1792366,"[GDE2025_Antiplatelet] Secondary outcome - NACE",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",0.380673677109538,0.140581148114588,1.5621400194425,0.11590260776723,819,16,221398,4251,57,3,-0.965812761379161,0.614303910124479,1.00881709733147
2,"OT - PS stratification",72418,"Scoliosis deformity of spine",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",4092565,"Uterine prolapse",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",4339088,"Testicular mass",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",4142905,"Fracture of rib",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,229474,6697,2,0,NA,NA,NA
2,"OT - PS stratification",4028970,"Tracheobronchitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",4047787,"Colles' fracture",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",4172458,"Candidiasis of skin",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",434626,"Borderline personality disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",4049417,"Vesicular eczema",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",134619,"Toxic nodular goiter",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",195212,"Hypercortisolism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",377535,"Sleep walking disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",73300,"Radial styloid tenosynovitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",4153877,"Post-traumatic wound infection",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",80509,"Bone cyst",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",435093,"Closed fracture of femur",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",632234853884228,0.0270335241286849,NA,NA,819,16,229954,6697,2,0,34.0802820452948,NA,0.0937807377524322
2,"OT - PS stratification",42873169,"Sprain of shoulder rotator cuff",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",4207307,"Infective meningitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,229359,6697,2,0,NA,NA,NA
2,"OT - PS stratification",4114197,"Tumor of hypothalamus",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",74586047118427.8,0.0325511530132877,NA,NA,819,16,229181,6697,4,0,31.9429745696989,NA,0.0795767597946231
2,"OT - PS stratification",444367,"Cholelithiasis without obstruction",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",198075,"Condyloma acuminatum of the anogenital region",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",4135082,"Dislocation of distal radioulnar joint",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",4239381,"Psychoactive substance abuse",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",261880,"Atelectasis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",114064145501677,0.0228879070218864,NA,NA,819,16,229559,6697,3,0,32.3677820859174,NA,0.0597776577121394
2,"OT - PS stratification",199074,"Acute pancreatitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,229968,6697,3,0,NA,NA,NA
2,"OT - PS stratification",4068482,"Prolapsed lumbar intervertebral disc",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",143148061670247,0.113710390455537,NA,NA,819,16,228209,6697,11,0,32.5949006068309,NA,0.285454169559415
2,"OT - PS stratification",440424,"Aphasia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",4150372,"Acute otitis media",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,229775,6697,1,0,NA,NA,NA
2,"OT - PS stratification",1792370,"[GDE2025_Antiplatelet] Secondary outcome - AMI",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",0.264323320574909,0.0794419242844285,1.63696130665786,0.0847255895838114,819,16,223829,6571,28,2,-1.3305822260207,0.771843442445152,1.1522418018958
2,"OT - PS stratification",198202,"Cystocele",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230127,6697,0,0,NA,NA,NA
2,"OT - PS stratification",75576,"Irritable bowel syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,228614,6697,5,0,NA,NA,NA
2,"OT - PS stratification",4215978,"Onychomycosis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",103377211751995,0.0397937956161968,NA,NA,819,16,226915,6697,5,0,32.2694056644679,NA,0.0998566387987871
2,"OT - PS stratification",140168,"Psoriasis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,229218,6697,3,0,NA,NA,NA
2,"OT - PS stratification",253796,"Pneumothorax",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,819,16,230076,6697,1,0,NA,NA,NA
3,"ITT(1mo) - PS matching",134619,"Toxic nodular goiter",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",377535,"Sleep walking disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",1792374,"[GDE2025_Antiplatelet] Secondary outcome - GI bleeding",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",380839,"Tuberous sclerosis syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",72418,"Scoliosis deformity of spine",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",1792365,"[GDE2025_Antiplatelet] Secondary outcome - Cardiovascular mortality",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",194997,"Prostatitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",30234,"Neck sprain",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",74189,"Sprain of cruciate ligament of knee",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",199861,"Perianal abscess",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",198202,"Cystocele",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",440129,"Hypertrophy of nasal turbinates",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",139902,"Allergic urticaria",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",135215,"Hashimoto thyroiditis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",77965,"Acquired trigger finger",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",75576,"Irritable bowel syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4172458,"Candidiasis of skin",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",81336,"Rectal prolapse",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",72576,"Benign tumor of breast",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",380395,"Retinal dystrophy",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",376707,"Acute conjunctivitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4047787,"Colles' fracture",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",376938,"Neurofibromatosis syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",261880,"Atelectasis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",440814,"Torticollis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",374366,"Sensorineural hearing loss",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",201792,"Nongonococcal urethritis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4049417,"Vesicular eczema",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4215978,"Onychomycosis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",433527,"Endometriosis (clinical)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",436675,"Anorexia nervosa",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",261326,"Viral pneumonia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",433440,"Dysthymia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",1792369,"[GDE2025_Antiplatelet] Secondary outcome - Ischemic event",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",433450,"Paranoid schizophrenia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4164337,"Polyp of large intestine",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",374655,"Mastoiditis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",140168,"Psoriasis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",373478,"Presbyopia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",444367,"Cholelithiasis without obstruction",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4223947,"Viral hepatitis, type A",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4171915,"Orchitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",381444,"Contusion of eye",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",74855,"Genital herpes simplex",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",141933,"Alopecia areata",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",376132,"Ectropion",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4079750,"Osteoarthritis of knee",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4001458,"Fatigue fracture of vertebra",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",133228,"Dental caries",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",440424,"Aphasia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4068482,"Prolapsed lumbar intervertebral disc",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",81878,"Benign paroxysmal positional vertigo",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",141323,"Acute maxillary sinusitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",318800,"Gastroesophageal reflux disease",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4092565,"Uterine prolapse",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",380094,"Carpal tunnel syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",381581,"Chalazion",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",134453,"Bursitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",192606,"Paraplegia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",432590,"Delusional disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",253796,"Pneumothorax",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4108467,"Burn of skin",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4207307,"Infective meningitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",197036,"Vesicoureteric reflux",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",194696,"Dysmenorrhea",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4288544,"Inguinal hernia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4114197,"Tumor of hypothalamus",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",80509,"Bone cyst",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",435613,"Cellulitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",1792368,"[GDE2025_Antiplatelet] Secondary outcome - Hemorrhagic event",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",140362,"Hypoparathyroidism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4218106,"Alcoholism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",198803,"Benign prostatic hyperplasia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",439840,"Lymphangitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4299544,"Acanthosis nigricans",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",1792364,"[GDE2025_Antiplatelet] Secondary outcome - All cause mortality",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",436100,"Narcolepsy",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4131595,"Fracture of radius",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",377910,"Deviated nasal septum",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",195212,"Hypercortisolism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",30441,"Sialolithiasis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",199074,"Acute pancreatitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4135082,"Dislocation of distal radioulnar joint",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",378424,"Astigmatism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4304008,"Memory impairment",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",1792370,"[GDE2025_Antiplatelet] Secondary outcome - AMI",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",316457,"Mallory-Weiss syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4239381,"Psychoactive substance abuse",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",138463,"Aphthous ulcer of mouth",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",1792371,"[GDE2025_Antiplatelet] Secondary Outcome - Stroke(both)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",436676,"Posttraumatic stress disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",434626,"Borderline personality disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",1792366,"[GDE2025_Antiplatelet] Secondary outcome - NACE",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4339088,"Testicular mass",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4142905,"Fracture of rib",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4028970,"Tracheobronchitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",40443308,"Polycystic ovary syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",1792372,"[GDE2025_Antiplatelet] Secondary outcome - Stroke(hemorrhagic)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",198075,"Condyloma acuminatum of the anogenital region",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4280571,"Acute pyelonephritis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",437082,"Ankylosing spondylitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4150372,"Acute otitis media",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",435093,"Closed fracture of femur",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",1792367,"[GDE2025_Antiplatelet] Primary outcome - MACE",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",1792373,"[GDE2025_Antiplatelet] Secondary outcome - Stroke(ischemic)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",42873169,"Sprain of shoulder rotator cuff",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",438407,"Bulimia nervosa",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",380731,"Otitis externa",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",73300,"Radial styloid tenosynovitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",4153877,"Post-traumatic wound infection",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
3,"ITT(1mo) - PS matching",134765,"Cachexia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",432590,"Delusional disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",198202,"Cystocele",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",75576,"Irritable bowel syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26667,510,5,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",141323,"Acute maxillary sinusitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",433450,"Paranoid schizophrenia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",433440,"Dysthymia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",376938,"Neurofibromatosis syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",1792370,"[GDE2025_Antiplatelet] Secondary outcome - AMI",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",0.0991181813907652,0.0118944156974338,0.825962766626654,0.0326213902313605,911,17,26340,456,23,2,-2.31144238938036,1.08177515208879,2.22780816194015
4,"ITT(1mo) - PS stratification",198803,"Benign prostatic hyperplasia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",0.926903969263828,0.174130411744182,17.0879928370092,0.948272587796752,911,17,25981,496,46,1,-0.0759053118095644,1.17000282849224,0.00254074974597529
4,"ITT(1mo) - PS stratification",4068482,"Prolapsed lumbar intervertebral disc",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26737,510,1,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",134765,"Cachexia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",199861,"Perianal abscess",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",1792366,"[GDE2025_Antiplatelet] Secondary outcome - NACE",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",0.335833080235017,0.0811333602309363,2.25406862561428,0.198231239561409,911,17,25864,456,57,2,-1.09114102747232,0.848076276680717,0.744834801769571
4,"ITT(1mo) - PS stratification",194696,"Dysmenorrhea",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26744,510,1,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",133228,"Dental caries",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",221994074639054,NA,NA,NA,911,17,26699,510,3,0,33.0336718066295,NA,0.0963918456750807
4,"ITT(1mo) - PS stratification",433527,"Endometriosis (clinical)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26726,510,1,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",4239381,"Psychoactive substance abuse",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",435613,"Cellulitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",4288544,"Inguinal hernia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",754679036160218,NA,NA,NA,911,17,26706,510,2,0,34.2573136571209,NA,0.0963918456750541
4,"ITT(1mo) - PS stratification",444367,"Cholelithiasis without obstruction",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",192606,"Paraplegia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",4001458,"Fatigue fracture of vertebra",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26710,510,2,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",380395,"Retinal dystrophy",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",197036,"Vesicoureteric reflux",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",4280571,"Acute pyelonephritis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26737,510,1,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",4047787,"Colles' fracture",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",81336,"Rectal prolapse",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",436100,"Narcolepsy",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",74855,"Genital herpes simplex",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",4215978,"Onychomycosis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26715,510,2,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",374655,"Mastoiditis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",30441,"Sialolithiasis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",1792373,"[GDE2025_Antiplatelet] Secondary outcome - Stroke(ischemic)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26737,510,1,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",81878,"Benign paroxysmal positional vertigo",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",374366,"Sensorineural hearing loss",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26749,510,1,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",140362,"Hypoparathyroidism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",141933,"Alopecia areata",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",1792369,"[GDE2025_Antiplatelet] Secondary outcome - Ischemic event",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",0.0991181813907652,0.0118944156974342,0.825962766626629,0.0326213902313579,911,17,26326,456,24,2,-2.31144238938036,1.08177515208878,2.22780816194017
4,"ITT(1mo) - PS stratification",72418,"Scoliosis deformity of spine",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",138463,"Aphthous ulcer of mouth",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",4164337,"Polyp of large intestine",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26709,510,2,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",194997,"Prostatitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,1,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",377910,"Deviated nasal septum",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26744,510,1,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",139902,"Allergic urticaria",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26750,510,1,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",434626,"Borderline personality disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",261880,"Atelectasis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",312801744033422,NA,NA,NA,911,17,26728,510,2,0,33.3765907001386,NA,0.0992066500834525
4,"ITT(1mo) - PS stratification",376707,"Acute conjunctivitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",1792365,"[GDE2025_Antiplatelet] Secondary outcome - Cardiovascular mortality",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",237237911457818,NA,NA,NA,911,17,26420,510,27,0,33.100084599361,NA,0.389010835448147
4,"ITT(1mo) - PS stratification",4079750,"Osteoarthritis of knee",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",206739817779573,NA,NA,NA,911,17,26718,510,2,0,32.9624821996695,NA,0.0992066500834525
4,"ITT(1mo) - PS stratification",440814,"Torticollis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",316457,"Mallory-Weiss syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",4207307,"Infective meningitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",1792372,"[GDE2025_Antiplatelet] Secondary outcome - Stroke(hemorrhagic)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26713,510,2,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",73300,"Radial styloid tenosynovitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",380839,"Tuberous sclerosis syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",80509,"Bone cyst",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",195212,"Hypercortisolism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",140168,"Psoriasis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",310257827153583,NA,NA,NA,911,17,26727,510,2,0,33.368424768232,NA,0.0963918456750612
4,"ITT(1mo) - PS stratification",380731,"Otitis externa",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",42873169,"Sprain of shoulder rotator cuff",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",435093,"Closed fracture of femur",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",318800,"Gastroesophageal reflux disease",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",1.32684265292103,0.480737658828068,5.49270175197842,0.649035207038651,911,17,22646,451,227,3,0.28280217478616,0.621402699638937,0.12057411211299
4,"ITT(1mo) - PS stratification",377535,"Sleep walking disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",261326,"Viral pneumonia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",440129,"Hypertrophy of nasal turbinates",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26747,510,1,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",30234,"Neck sprain",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26735,510,1,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",199074,"Acute pancreatitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",331419958152813,NA,NA,NA,911,17,26698,510,3,0,33.4344074428639,NA,0.0963918456750523
4,"ITT(1mo) - PS stratification",4218106,"Alcoholism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26709,510,2,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",1792364,"[GDE2025_Antiplatelet] Secondary outcome - All cause mortality",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",320193742311510,NA,NA,NA,911,17,26397,510,28,0,33.3999473732381,NA,0.48599941315544
4,"ITT(1mo) - PS stratification",1792371,"[GDE2025_Antiplatelet] Secondary Outcome - Stroke(both)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26699,510,3,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",1792374,"[GDE2025_Antiplatelet] Secondary outcome - GI bleeding",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",124452899147314,NA,NA,NA,911,17,26589,510,12,0,32.4549484401503,NA,0.0992066500834952
4,"ITT(1mo) - PS stratification",4131595,"Fracture of radius",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26734,510,1,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",436675,"Anorexia nervosa",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",135215,"Hashimoto thyroiditis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26743,510,1,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",438407,"Bulimia nervosa",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",1792367,"[GDE2025_Antiplatelet] Primary outcome - MACE",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",0.335833080235017,0.0811333602309457,2.2540686256145,0.198231239561406,911,17,26001,456,50,2,-1.09114102747232,0.848076276680712,0.7448348017694
4,"ITT(1mo) - PS stratification",4171915,"Orchitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",437082,"Ankylosing spondylitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",4135082,"Dislocation of distal radioulnar joint",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",4172458,"Candidiasis of skin",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",4092565,"Uterine prolapse",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",436676,"Posttraumatic stress disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26739,510,1,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",4114197,"Tumor of hypothalamus",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",310257827153583,NA,NA,NA,911,17,26716,510,2,0,33.368424768232,NA,0.0963918456750577
4,"ITT(1mo) - PS stratification",378424,"Astigmatism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",4142905,"Fracture of rib",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",134619,"Toxic nodular goiter",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",77965,"Acquired trigger finger",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",134453,"Bursitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",4049417,"Vesicular eczema",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",72576,"Benign tumor of breast",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",1792368,"[GDE2025_Antiplatelet] Secondary outcome - Hemorrhagic event",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",150782514911694,3.11409100903022e-09,NA,NA,911,17,26551,510,14,0,32.6468596159184,NA,0.0992066500833175
4,"ITT(1mo) - PS stratification",440424,"Aphasia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",439840,"Lymphangitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",40443308,"Polycystic ovary syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",380094,"Carpal tunnel syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",4223947,"Viral hepatitis, type A",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",4108467,"Burn of skin",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",4339088,"Testicular mass",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",381581,"Chalazion",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",4299544,"Acanthosis nigricans",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",4304008,"Memory impairment",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",376132,"Ectropion",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",201792,"Nongonococcal urethritis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",74189,"Sprain of cruciate ligament of knee",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",373478,"Presbyopia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26743,510,1,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",4028970,"Tracheobronchitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",253796,"Pneumothorax",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26745,510,1,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",4153877,"Post-traumatic wound infection",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",381444,"Contusion of eye",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",198075,"Condyloma acuminatum of the anogenital region",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
4,"ITT(1mo) - PS stratification",4150372,"Acute otitis media",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,26751,510,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",261326,"Viral pneumonia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",30441,"Sialolithiasis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",4001458,"Fatigue fracture of vertebra",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,77842,1530,2,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",139902,"Allergic urticaria",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,77917,1530,2,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",75576,"Irritable bowel syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",116161156918765,NA,NA,NA,911,17,77567,1530,7,0,32.3859996266555,NA,0.101579792817937
5,"ITT(3mo) - PS stratification",201792,"Nongonococcal urethritis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",197036,"Vesicoureteric reflux",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",140362,"Hypoparathyroidism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",81336,"Rectal prolapse",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",4218106,"Alcoholism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,77841,1530,2,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",4028970,"Tracheobronchitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",77965,"Acquired trigger finger",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",377910,"Deviated nasal septum",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,77936,1530,1,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",376707,"Acute conjunctivitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",374366,"Sensorineural hearing loss",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",7.60595091022817e-10,2.43080472882866e-27,0.619002729394713,0.17583818770356,911,17,77912,1499,2,1,-20.9969199745404,15.5109813309924,2.34293637420053
5,"ITT(3mo) - PS stratification",432590,"Delusional disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",140168,"Psoriasis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",296304003770741,0.0207411170920506,NA,NA,911,17,77859,1530,3,0,33.3224070829741,NA,0.0963918456750612
5,"ITT(3mo) - PS stratification",4047787,"Colles' fracture",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,1,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",373478,"Presbyopia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,77935,1530,1,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",436100,"Narcolepsy",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,77981,1530,1,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",195212,"Hypercortisolism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",4339088,"Testicular mass",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",199074,"Acute pancreatitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",301666620861304,NA,NA,NA,911,17,77770,1530,3,0,33.3403436191194,NA,0.0963918456750665
5,"ITT(3mo) - PS stratification",74189,"Sprain of cruciate ligament of knee",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",30234,"Neck sprain",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,77927,1530,1,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",4223947,"Viral hepatitis, type A",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",440129,"Hypertrophy of nasal turbinates",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",5.14617113050698e-10,3.71634387774005e-28,0.622894374808893,0.181085682012904,911,17,77939,1515,1,1,-21.38759796158,15.9916877107067,2.33727064135556
5,"ITT(3mo) - PS stratification",4131595,"Fracture of radius",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",314747042275764,NA,NA,NA,911,17,77885,1530,3,0,33.3827903917501,NA,0.100975917339992
5,"ITT(3mo) - PS stratification",4164337,"Polyp of large intestine",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,77841,1530,2,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",436675,"Anorexia nervosa",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",440814,"Torticollis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",1792366,"[GDE2025_Antiplatelet] Secondary outcome - NACE",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",0.383911545401882,0.0961494365948879,2.54369731322795,0.251918083591713,911,17,74474,1356,69,2,-0.957343103445098,0.835594518623375,0.599560250913839
5,"ITT(3mo) - PS stratification",381581,"Chalazion",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",4092565,"Uterine prolapse",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",1792374,"[GDE2025_Antiplatelet] Secondary outcome - GI bleeding",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",57098007771048.6,NA,NA,NA,911,17,77109,1530,19,0,31.6757903418076,NA,0.0992066500833602
5,"ITT(3mo) - PS stratification",433527,"Endometriosis (clinical)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,77918,1530,1,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",4079750,"Osteoarthritis of knee",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",0.105931854587096,0.0041927251433896,2.67643535707411,0.173047919203649,911,17,77850,1526,2,1,-2.24495927286064,1.64770634402324,1.06000183805417
5,"ITT(3mo) - PS stratification",1792367,"[GDE2025_Antiplatelet] Primary outcome - MACE",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",0.38391154540189,0.0961494365948735,2.54369731322811,0.251918083591754,911,17,75178,1356,57,2,-0.957343103445076,0.835594518623428,0.599560250913783
5,"ITT(3mo) - PS stratification",4280571,"Acute pyelonephritis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,77884,1530,3,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",4049417,"Vesicular eczema",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",437082,"Ankylosing spondylitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,77931,1530,2,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",198202,"Cystocele",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",376938,"Neurofibromatosis syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",141933,"Alopecia areata",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",73300,"Radial styloid tenosynovitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",380395,"Retinal dystrophy",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",1792373,"[GDE2025_Antiplatelet] Secondary outcome - Stroke(ischemic)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",695309258935578,0.0201890590290964,NA,NA,911,17,77920,1530,2,0,34.1753778394062,NA,0.101579792817915
5,"ITT(3mo) - PS stratification",141323,"Acute maxillary sinusitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",1792368,"[GDE2025_Antiplatelet] Secondary outcome - Hemorrhagic event",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",84908342541147.5,4.39508302354136e-09,NA,NA,911,17,76951,1530,21,0,32.072593467565,NA,0.0992066500833602
5,"ITT(3mo) - PS stratification",134765,"Cachexia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",4288544,"Inguinal hernia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",296304003770741,0.0207411170920508,NA,NA,911,17,77829,1530,3,0,33.3224070829741,NA,0.0963918456750612
5,"ITT(3mo) - PS stratification",380731,"Otitis externa",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",380094,"Carpal tunnel syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",435613,"Cellulitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,77928,1530,3,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",138463,"Aphthous ulcer of mouth",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",199861,"Perianal abscess",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",439840,"Lymphangitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",1792364,"[GDE2025_Antiplatelet] Secondary outcome - All cause mortality",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",320193742311510,NA,NA,NA,911,17,77193,1530,30,0,33.3999473732381,NA,0.485999413155554
5,"ITT(3mo) - PS stratification",433450,"Paranoid schizophrenia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",74855,"Genital herpes simplex",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",72576,"Benign tumor of breast",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",261880,"Atelectasis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",206935048456465,NA,NA,NA,911,17,77802,1530,3,0,32.9634260843834,NA,0.0992066500834525
5,"ITT(3mo) - PS stratification",4304008,"Memory impairment",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",440424,"Aphasia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",1792370,"[GDE2025_Antiplatelet] Secondary outcome - AMI",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",0.0991181813907652,0.0118944156974336,0.825962766626657,0.0326213902313612,911,17,76102,1356,28,2,-2.31144238938036,1.0817751520888,2.22780816194017
5,"ITT(3mo) - PS stratification",194997,"Prostatitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,77943,1530,1,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",434626,"Borderline personality disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",40443308,"Polycystic ovary syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",4135082,"Dislocation of distal radioulnar joint",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",378424,"Astigmatism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",207966767883427,0.0190008407327476,NA,NA,911,17,77914,1530,3,0,32.9683994130741,NA,0.100975917339994
5,"ITT(3mo) - PS stratification",72418,"Scoliosis deformity of spine",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,77992,1530,1,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",4142905,"Fracture of rib",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",1792372,"[GDE2025_Antiplatelet] Secondary outcome - Stroke(hemorrhagic)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,77845,1530,2,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",4172458,"Candidiasis of skin",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",134453,"Bursitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",198075,"Condyloma acuminatum of the anogenital region",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",377535,"Sleep walking disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",436676,"Posttraumatic stress disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,77931,1530,1,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",318800,"Gastroesophageal reflux disease",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",1.05282192342029,0.424639996338119,3.50680682907573,0.923860006739112,911,17,60439,1288,252,4,0.0514741052895531,0.538586280468985,0.00488519554505729
5,"ITT(3mo) - PS stratification",1792371,"[GDE2025_Antiplatelet] Secondary Outcome - Stroke(both)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",208548064818827,0.0225018552666456,NA,NA,911,17,77762,1530,4,0,32.9711906573092,NA,0.101579792817905
5,"ITT(3mo) - PS stratification",4150372,"Acute otitis media",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",4207307,"Infective meningitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,77959,1530,1,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",381444,"Contusion of eye",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",435093,"Closed fracture of femur",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",80509,"Bone cyst",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",135215,"Hashimoto thyroiditis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",226775132965768,NA,NA,NA,911,17,77924,1530,2,0,33.0549800387628,NA,0.201397590979999
5,"ITT(3mo) - PS stratification",194696,"Dysmenorrhea",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,77936,1530,1,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",438407,"Bulimia nervosa",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",433440,"Dysthymia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,77953,1530,1,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",380839,"Tuberous sclerosis syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",198803,"Benign prostatic hyperplasia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",1.24346644564725,0.244969233301614,22.6425173226645,0.850324045932761,911,17,73979,1456,65,1,0.217903000099305,1.15472838447681,0.0233109512897158
5,"ITT(3mo) - PS stratification",4114197,"Tumor of hypothalamus",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",333060548204974,NA,NA,NA,911,17,77808,1530,3,0,33.4393454158219,NA,0.197971638492978
5,"ITT(3mo) - PS stratification",133228,"Dental caries",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",296377959593088,0.0269844623626638,NA,NA,911,17,77742,1530,4,0,33.3226566462384,NA,0.096391845675079
5,"ITT(3mo) - PS stratification",1792369,"[GDE2025_Antiplatelet] Secondary outcome - Ischemic event",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",0.147609796041312,0.0244572371699348,1.12078673008465,0.0499098612448793,911,17,76019,1356,30,2,-1.9131830001745,0.975747517441315,1.74118922163498
5,"ITT(3mo) - PS stratification",316457,"Mallory-Weiss syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",4299544,"Acanthosis nigricans",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",42873169,"Sprain of shoulder rotator cuff",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",374655,"Mastoiditis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",4171915,"Orchitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",192606,"Paraplegia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78000,1530,1,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",81878,"Benign paroxysmal positional vertigo",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,77999,1530,1,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",134619,"Toxic nodular goiter",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",376132,"Ectropion",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",4153877,"Post-traumatic wound infection",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",4215978,"Onychomycosis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,77843,1530,3,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",4068482,"Prolapsed lumbar intervertebral disc",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",685234615388355,1.25555590206416e-09,NA,NA,911,17,77877,1530,2,0,34.1607823997662,NA,0.100379185307631
5,"ITT(3mo) - PS stratification",4239381,"Psychoactive substance abuse",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",253796,"Pneumothorax",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,77937,1530,1,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",444367,"Cholelithiasis without obstruction",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
5,"ITT(3mo) - PS stratification",1792365,"[GDE2025_Antiplatelet] Secondary outcome - Cardiovascular mortality",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",237237911457818,NA,NA,NA,911,17,77231,1530,29,0,33.100084599361,NA,0.389010835448317
5,"ITT(3mo) - PS stratification",4108467,"Burn of skin",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,78003,1530,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",1792371,"[GDE2025_Antiplatelet] Secondary Outcome - Stroke(both)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",374655,"Mastoiditis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4001458,"Fatigue fracture of vertebra",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",140168,"Psoriasis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",378424,"Astigmatism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",80509,"Bone cyst",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",195212,"Hypercortisolism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",380395,"Retinal dystrophy",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",433450,"Paranoid schizophrenia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",438407,"Bulimia nervosa",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",380839,"Tuberous sclerosis syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4288544,"Inguinal hernia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",141933,"Alopecia areata",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",1792374,"[GDE2025_Antiplatelet] Secondary outcome - GI bleeding",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",374366,"Sensorineural hearing loss",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",138463,"Aphthous ulcer of mouth",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",81878,"Benign paroxysmal positional vertigo",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",373478,"Presbyopia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",141323,"Acute maxillary sinusitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",437082,"Ankylosing spondylitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4114197,"Tumor of hypothalamus",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",30441,"Sialolithiasis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",436675,"Anorexia nervosa",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",253796,"Pneumothorax",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",140362,"Hypoparathyroidism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4299544,"Acanthosis nigricans",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4223947,"Viral hepatitis, type A",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",381444,"Contusion of eye",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",72418,"Scoliosis deformity of spine",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",261880,"Atelectasis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",439840,"Lymphangitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",75576,"Irritable bowel syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4079750,"Osteoarthritis of knee",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",436100,"Narcolepsy",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",1792366,"[GDE2025_Antiplatelet] Secondary outcome - NACE",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",134453,"Bursitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",376707,"Acute conjunctivitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4108467,"Burn of skin",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",316457,"Mallory-Weiss syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",40443308,"Polycystic ovary syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",194696,"Dysmenorrhea",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",440814,"Torticollis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",1792364,"[GDE2025_Antiplatelet] Secondary outcome - All cause mortality",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",42873169,"Sprain of shoulder rotator cuff",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",134619,"Toxic nodular goiter",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",376938,"Neurofibromatosis syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4049417,"Vesicular eczema",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",433440,"Dysthymia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",261326,"Viral pneumonia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",1792368,"[GDE2025_Antiplatelet] Secondary outcome - Hemorrhagic event",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",377535,"Sleep walking disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4131595,"Fracture of radius",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",444367,"Cholelithiasis without obstruction",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",134765,"Cachexia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",435613,"Cellulitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",1792365,"[GDE2025_Antiplatelet] Secondary outcome - Cardiovascular mortality",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",30234,"Neck sprain",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",198803,"Benign prostatic hyperplasia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4164337,"Polyp of large intestine",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",377910,"Deviated nasal septum",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",1792369,"[GDE2025_Antiplatelet] Secondary outcome - Ischemic event",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4304008,"Memory impairment",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4171915,"Orchitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",197036,"Vesicoureteric reflux",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",433527,"Endometriosis (clinical)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4280571,"Acute pyelonephritis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",77965,"Acquired trigger finger",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",1792370,"[GDE2025_Antiplatelet] Secondary outcome - AMI",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4207307,"Infective meningitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4339088,"Testicular mass",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4028970,"Tracheobronchitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4172458,"Candidiasis of skin",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",192606,"Paraplegia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",318800,"Gastroesophageal reflux disease",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",381581,"Chalazion",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",72576,"Benign tumor of breast",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",434626,"Borderline personality disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",436676,"Posttraumatic stress disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4218106,"Alcoholism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",380731,"Otitis externa",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",1792372,"[GDE2025_Antiplatelet] Secondary outcome - Stroke(hemorrhagic)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",440129,"Hypertrophy of nasal turbinates",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4047787,"Colles' fracture",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",1792367,"[GDE2025_Antiplatelet] Primary outcome - MACE",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4068482,"Prolapsed lumbar intervertebral disc",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",73300,"Radial styloid tenosynovitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",435093,"Closed fracture of femur",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",198075,"Condyloma acuminatum of the anogenital region",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4215978,"Onychomycosis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",1792373,"[GDE2025_Antiplatelet] Secondary outcome - Stroke(ischemic)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",81336,"Rectal prolapse",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",199074,"Acute pancreatitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",74189,"Sprain of cruciate ligament of knee",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",139902,"Allergic urticaria",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4153877,"Post-traumatic wound infection",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",135215,"Hashimoto thyroiditis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",199861,"Perianal abscess",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4142905,"Fracture of rib",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",133228,"Dental caries",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4135082,"Dislocation of distal radioulnar joint",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",380094,"Carpal tunnel syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4150372,"Acute otitis media",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",74855,"Genital herpes simplex",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",440424,"Aphasia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4239381,"Psychoactive substance abuse",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",198202,"Cystocele",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",194997,"Prostatitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",4092565,"Uterine prolapse",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",201792,"Nongonococcal urethritis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",376132,"Ectropion",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
6,"ITT(3mo) - PS matching",432590,"Delusional disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",376132,"Ectropion",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",80509,"Bone cyst",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",74189,"Sprain of cruciate ligament of knee",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",261880,"Atelectasis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4135082,"Dislocation of distal radioulnar joint",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",197036,"Vesicoureteric reflux",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",440129,"Hypertrophy of nasal turbinates",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",40443308,"Polycystic ovary syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4239381,"Psychoactive substance abuse",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4142905,"Fracture of rib",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",435613,"Cellulitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",433440,"Dysthymia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",436100,"Narcolepsy",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",1792369,"[GDE2025_Antiplatelet] Secondary outcome - Ischemic event",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",376707,"Acute conjunctivitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",381444,"Contusion of eye",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",134765,"Cachexia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4049417,"Vesicular eczema",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",139902,"Allergic urticaria",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4068482,"Prolapsed lumbar intervertebral disc",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",1792364,"[GDE2025_Antiplatelet] Secondary outcome - All cause mortality",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",81336,"Rectal prolapse",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",436675,"Anorexia nervosa",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",380839,"Tuberous sclerosis syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",74855,"Genital herpes simplex",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",134619,"Toxic nodular goiter",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4304008,"Memory impairment",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4150372,"Acute otitis media",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4207307,"Infective meningitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",141933,"Alopecia areata",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4047787,"Colles' fracture",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",1792372,"[GDE2025_Antiplatelet] Secondary outcome - Stroke(hemorrhagic)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",376938,"Neurofibromatosis syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4114197,"Tumor of hypothalamus",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",433527,"Endometriosis (clinical)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",72418,"Scoliosis deformity of spine",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4153877,"Post-traumatic wound infection",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4028970,"Tracheobronchitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",199074,"Acute pancreatitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",380731,"Otitis externa",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",30234,"Neck sprain",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",140362,"Hypoparathyroidism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",194997,"Prostatitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",194696,"Dysmenorrhea",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",374366,"Sensorineural hearing loss",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",1792374,"[GDE2025_Antiplatelet] Secondary outcome - GI bleeding",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",141323,"Acute maxillary sinusitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",435093,"Closed fracture of femur",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",432590,"Delusional disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",135215,"Hashimoto thyroiditis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",140168,"Psoriasis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",377910,"Deviated nasal septum",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4001458,"Fatigue fracture of vertebra",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",81878,"Benign paroxysmal positional vertigo",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",316457,"Mallory-Weiss syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",133228,"Dental caries",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",377535,"Sleep walking disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",1792367,"[GDE2025_Antiplatelet] Primary outcome - MACE",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4223947,"Viral hepatitis, type A",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",199861,"Perianal abscess",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4131595,"Fracture of radius",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4288544,"Inguinal hernia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",201792,"Nongonococcal urethritis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4299544,"Acanthosis nigricans",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",434626,"Borderline personality disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",1792366,"[GDE2025_Antiplatelet] Secondary outcome - NACE",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",380094,"Carpal tunnel syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",134453,"Bursitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",77965,"Acquired trigger finger",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4079750,"Osteoarthritis of knee",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4171915,"Orchitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",373478,"Presbyopia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",198202,"Cystocele",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",381581,"Chalazion",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4339088,"Testicular mass",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",380395,"Retinal dystrophy",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",437082,"Ankylosing spondylitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",1792373,"[GDE2025_Antiplatelet] Secondary outcome - Stroke(ischemic)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",261326,"Viral pneumonia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",73300,"Radial styloid tenosynovitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",438407,"Bulimia nervosa",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4218106,"Alcoholism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",1792368,"[GDE2025_Antiplatelet] Secondary outcome - Hemorrhagic event",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",253796,"Pneumothorax",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",198803,"Benign prostatic hyperplasia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",138463,"Aphthous ulcer of mouth",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",195212,"Hypercortisolism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4164337,"Polyp of large intestine",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",75576,"Irritable bowel syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",433450,"Paranoid schizophrenia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4108467,"Burn of skin",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",439840,"Lymphangitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",1792370,"[GDE2025_Antiplatelet] Secondary outcome - AMI",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",72576,"Benign tumor of breast",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4092565,"Uterine prolapse",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",378424,"Astigmatism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4215978,"Onychomycosis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",440814,"Torticollis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4280571,"Acute pyelonephritis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",440424,"Aphasia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",1792371,"[GDE2025_Antiplatelet] Secondary Outcome - Stroke(both)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",4172458,"Candidiasis of skin",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",318800,"Gastroesophageal reflux disease",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",42873169,"Sprain of shoulder rotator cuff",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",198075,"Condyloma acuminatum of the anogenital region",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",374655,"Mastoiditis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",1792365,"[GDE2025_Antiplatelet] Secondary outcome - Cardiovascular mortality",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",436676,"Posttraumatic stress disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",192606,"Paraplegia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",444367,"Cholelithiasis without obstruction",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
7,"ITT(1y) - PS matching",30441,"Sialolithiasis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",377910,"Deviated nasal septum",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",231072874525703,NA,NA,NA,911,17,293701,5612,5,0,33.0737542508361,NA,0.19198838353439
8,"ITT(1y) - PS stratification",75576,"Irritable bowel syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",116161156918765,NA,NA,NA,911,17,292012,5612,8,0,32.3859996266555,NA,0.101579792817937
8,"ITT(1y) - PS stratification",4218106,"Alcoholism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294018,5612,3,0,NA,NA,NA
8,"ITT(1y) - PS stratification",374655,"Mastoiditis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",432590,"Delusional disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",253796,"Pneumothorax",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294134,5612,1,0,NA,NA,NA
8,"ITT(1y) - PS stratification",81336,"Rectal prolapse",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294218,5612,1,0,NA,NA,NA
8,"ITT(1y) - PS stratification",74855,"Genital herpes simplex",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",261326,"Viral pneumonia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",199861,"Perianal abscess",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",42873169,"Sprain of shoulder rotator cuff",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",436675,"Anorexia nervosa",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",437082,"Ankylosing spondylitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,293853,5612,2,0,NA,NA,NA
8,"ITT(1y) - PS stratification",444367,"Cholelithiasis without obstruction",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",380731,"Otitis externa",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",284501258334332,NA,NA,NA,911,17,294014,5612,3,0,33.2817587924529,NA,0.0953101798043203
8,"ITT(1y) - PS stratification",72576,"Benign tumor of breast",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",77965,"Acquired trigger finger",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294264,5612,1,0,NA,NA,NA
8,"ITT(1y) - PS stratification",439840,"Lymphangitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",434626,"Borderline personality disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",373478,"Presbyopia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,293695,5612,4,0,NA,NA,NA
8,"ITT(1y) - PS stratification",440814,"Torticollis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",4150372,"Acute otitis media",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294101,5612,2,0,NA,NA,NA
8,"ITT(1y) - PS stratification",376132,"Ectropion",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",436100,"Narcolepsy",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294178,5612,1,0,NA,NA,NA
8,"ITT(1y) - PS stratification",72418,"Scoliosis deformity of spine",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294180,5612,2,0,NA,NA,NA
8,"ITT(1y) - PS stratification",1792364,"[GDE2025_Antiplatelet] Secondary outcome - All cause mortality",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",272694599932302,2.18245544759577e-09,NA,NA,911,17,292036,5612,44,0,33.2393736033556,NA,0.675445593044003
8,"ITT(1y) - PS stratification",80509,"Bone cyst",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",4153877,"Post-traumatic wound infection",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",194696,"Dysmenorrhea",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294133,5612,1,0,NA,NA,NA
8,"ITT(1y) - PS stratification",30441,"Sialolithiasis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",199074,"Acute pancreatitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",281314780391259,NA,NA,NA,911,17,293780,5612,3,0,33.2704953732053,NA,0.0963918456750736
8,"ITT(1y) - PS stratification",134453,"Bursitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294463,5612,1,0,NA,NA,NA
8,"ITT(1y) - PS stratification",198803,"Benign prostatic hyperplasia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",1.3395922457027,0.266817315926565,24.3239014910412,0.79952336469159,911,17,271775,5263,85,1,0.292365273404214,1.15120751395214,0.0431711081635058
8,"ITT(1y) - PS stratification",30234,"Neck sprain",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294124,5612,1,0,NA,NA,NA
8,"ITT(1y) - PS stratification",194997,"Prostatitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294140,5612,1,0,NA,NA,NA
8,"ITT(1y) - PS stratification",4299544,"Acanthosis nigricans",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",1792366,"[GDE2025_Antiplatelet] Secondary outcome - NACE",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",0.371608347096061,0.118005412045253,1.63118603624902,0.139542783492647,911,17,276085,4880,96,3,-0.989914809711146,0.669995007897937,0.954740885587569
8,"ITT(1y) - PS stratification",1792374,"[GDE2025_Antiplatelet] Secondary outcome - GI bleeding",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",0.29803212083505,0.0381628988285382,6.02294156535415,0.348485274358554,911,17,289227,5604,24,1,-1.21055401024836,1.29121434939636,0.438638621746549
8,"ITT(1y) - PS stratification",4171915,"Orchitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",380395,"Retinal dystrophy",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",261880,"Atelectasis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",294825850156874,NA,NA,NA,911,17,293606,5612,4,0,33.3174059594987,NA,0.0992066500834596
8,"ITT(1y) - PS stratification",135215,"Hashimoto thyroiditis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,293643,5612,3,0,NA,NA,NA
8,"ITT(1y) - PS stratification",140362,"Hypoparathyroidism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",4135082,"Dislocation of distal radioulnar joint",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",1792373,"[GDE2025_Antiplatelet] Secondary outcome - Stroke(ischemic)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",208548064818827,0.0186082542585459,NA,NA,911,17,293577,5612,3,0,32.9711906573092,NA,0.101579792817905
8,"ITT(1y) - PS stratification",316457,"Mallory-Weiss syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",4001458,"Fatigue fracture of vertebra",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,293076,5612,7,0,NA,NA,NA
8,"ITT(1y) - PS stratification",4207307,"Infective meningitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,293890,5612,2,0,NA,NA,NA
8,"ITT(1y) - PS stratification",74189,"Sprain of cruciate ligament of knee",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",1792367,"[GDE2025_Antiplatelet] Primary outcome - MACE",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",0.473067459227836,0.124636567094792,3.07832584699029,0.360196947860238,911,17,280246,4888,79,2,-0.748517280727461,0.818060729210049,0.393866931214916
8,"ITT(1y) - PS stratification",381444,"Contusion of eye",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294353,5612,1,0,NA,NA,NA
8,"ITT(1y) - PS stratification",1792369,"[GDE2025_Antiplatelet] Secondary outcome - Ischemic event",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",0.147609796041312,0.024457237169937,1.12078673008461,0.0499098612448714,911,17,282939,4888,42,2,-1.9131830001745,0.975747517441282,1.74118922163507
8,"ITT(1y) - PS stratification",4164337,"Polyp of large intestine",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,293068,5612,8,0,NA,NA,NA
8,"ITT(1y) - PS stratification",436676,"Posttraumatic stress disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294128,5612,1,0,NA,NA,NA
8,"ITT(1y) - PS stratification",4339088,"Testicular mass",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",4092565,"Uterine prolapse",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",141323,"Acute maxillary sinusitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",4223947,"Viral hepatitis, type A",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",318800,"Gastroesophageal reflux disease",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",1.31386771697602,0.536638643765573,4.3477615810418,0.609021564963342,911,17,212064,4530,299,4,0.272975242982494,0.533706608313113,0.149184302542835
8,"ITT(1y) - PS stratification",198075,"Condyloma acuminatum of the anogenital region",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",1792368,"[GDE2025_Antiplatelet] Secondary outcome - Hemorrhagic event",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",0.39686068661852,0.0587052924580596,7.75837694783858,0.4582420693949,911,17,288187,5604,29,1,-0.924169975198724,1.24594089221126,0.281414395037217
8,"ITT(1y) - PS stratification",376938,"Neurofibromatosis syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",4068482,"Prolapsed lumbar intervertebral disc",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",249397361180708,NA,NA,NA,911,17,293009,5612,8,0,33.1500685684477,NA,0.198617624891014
8,"ITT(1y) - PS stratification",435093,"Closed fracture of femur",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294348,5612,3,0,NA,NA,NA
8,"ITT(1y) - PS stratification",141933,"Alopecia areata",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",201792,"Nongonococcal urethritis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",4131595,"Fracture of radius",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",207966767892392,0.019887140536751,NA,NA,911,17,293807,5612,3,0,32.9683994131172,NA,0.100975917340014
8,"ITT(1y) - PS stratification",4049417,"Vesicular eczema",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",198202,"Cystocele",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",134619,"Toxic nodular goiter",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",192606,"Paraplegia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294472,5612,1,0,NA,NA,NA
8,"ITT(1y) - PS stratification",433440,"Dysthymia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",687420225227575,0.0187432432256566,NA,NA,911,17,293947,5612,2,0,34.163966902704,NA,0.0929461125094484
8,"ITT(1y) - PS stratification",4215978,"Onychomycosis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,292771,5612,6,0,NA,NA,NA
8,"ITT(1y) - PS stratification",1792365,"[GDE2025_Antiplatelet] Secondary outcome - Cardiovascular mortality",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",148560761825541,3.14196969002896e-09,NA,NA,911,17,292320,5612,35,0,32.6320151610262,NA,0.48253689345799
8,"ITT(1y) - PS stratification",433450,"Paranoid schizophrenia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",40443308,"Polycystic ovary syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",4108467,"Burn of skin",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",134765,"Cachexia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",1792370,"[GDE2025_Antiplatelet] Secondary outcome - AMI",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",0.0991181813907655,0.011894415697433,0.825962766626785,0.03262139023137,911,17,283837,4888,39,2,-2.31144238938036,1.08177515208885,2.22780816194012
8,"ITT(1y) - PS stratification",138463,"Aphthous ulcer of mouth",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",440424,"Aphasia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",4028970,"Tracheobronchitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",4114197,"Tumor of hypothalamus",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",220302749386151,0.0745343313390079,NA,NA,911,17,293137,5612,6,0,33.0260238498503,NA,0.197971638492945
8,"ITT(1y) - PS stratification",4288544,"Inguinal hernia",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",342101238810661,1.90480711982103e-09,NA,NA,911,17,293432,5612,4,0,33.4661278291001,NA,0.189173579126017
8,"ITT(1y) - PS stratification",440129,"Hypertrophy of nasal turbinates",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",5.48003402118616e-10,5.58115382203923e-28,0.622894640322743,0.179532448159346,911,17,294136,5322,1,1,-21.3247396207542,15.8879473476994,2.33727064073105
8,"ITT(1y) - PS stratification",4304008,"Memory impairment",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",378424,"Astigmatism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",174721907064263,2.85059898809672e-09,NA,NA,911,17,291545,5612,17,0,32.7942167233996,NA,0.296579738606866
8,"ITT(1y) - PS stratification",380094,"Carpal tunnel syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294380,5612,1,0,NA,NA,NA
8,"ITT(1y) - PS stratification",140168,"Psoriasis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",220585136106117,NA,NA,NA,911,17,293245,5612,4,0,33.0273048410858,NA,0.0963918456750719
8,"ITT(1y) - PS stratification",1792372,"[GDE2025_Antiplatelet] Secondary outcome - Stroke(hemorrhagic)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",190146779469594,NA,NA,NA,911,17,293435,5612,5,0,32.8788174133705,NA,0.0929461125094235
8,"ITT(1y) - PS stratification",1792371,"[GDE2025_Antiplatelet] Secondary Outcome - Stroke(both)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",255434311653578,NA,NA,NA,911,17,292537,5612,8,0,33.1739863952709,NA,0.19510585082876
8,"ITT(1y) - PS stratification",73300,"Radial styloid tenosynovitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",81878,"Benign paroxysmal positional vertigo",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",687420225227575,0.0187432432256565,NA,NA,911,17,293966,5612,2,0,34.163966902704,NA,0.0929461125094484
8,"ITT(1y) - PS stratification",197036,"Vesicoureteric reflux",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",374366,"Sensorineural hearing loss",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",1.24640795073828e-09,NA,0.61900399473148,NA,911,17,293017,5306,7,1,-20.5030000618704,NA,2.34293636505588
8,"ITT(1y) - PS stratification",4079750,"Osteoarthritis of knee",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",0.105931854587095,0.00419272514338978,2.67643535707407,0.173047919203644,911,17,293005,5333,9,1,-2.24495927286065,1.64770634402322,1.0600018380542
8,"ITT(1y) - PS stratification",4047787,"Colles' fracture",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,1,0,NA,NA,NA
8,"ITT(1y) - PS stratification",381581,"Chalazion",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",4172458,"Candidiasis of skin",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",4280571,"Acute pyelonephritis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",246548957400534,NA,NA,NA,911,17,293247,5612,7,0,33.1385816998351,NA,0.0921704597996396
8,"ITT(1y) - PS stratification",376707,"Acute conjunctivitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294456,5612,1,0,NA,NA,NA
8,"ITT(1y) - PS stratification",4239381,"Psychoactive substance abuse",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",435613,"Cellulitis",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,293286,5612,5,0,NA,NA,NA
8,"ITT(1y) - PS stratification",195212,"Hypercortisolism",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",4142905,"Fracture of rib",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294167,5612,2,0,NA,NA,NA
8,"ITT(1y) - PS stratification",377535,"Sleep walking disorder",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",133228,"Dental caries",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",0.198168238850682,0.0189868582665205,4.26116291289408,0.24117725553859,911,17,292274,5381,8,1,-1.61863891790573,1.38103311063104,0.685652944104142
8,"ITT(1y) - PS stratification",380839,"Tuberous sclerosis syndrome",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
8,"ITT(1y) - PS stratification",139902,"Allergic urticaria",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",267982136396828,0.0244206755009876,NA,NA,911,17,293488,5612,4,0,33.2219414389821,NA,0.0929461125094484
8,"ITT(1y) - PS stratification",433527,"Endometriosis (clinical)",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294115,5612,1,0,NA,NA,NA
8,"ITT(1y) - PS stratification",438407,"Bulimia nervosa",1793457,"[GDE2025_Antiplatelet] Prasugrel cohort - Revised (2025.06.17)",1792797,"[GDE2025_Antiplatelet] Ticagrelor cohort - Revised (2025.06.17)",NA,NA,NA,NA,911,17,294475,5612,0,0,NA,NA,NA
